Medevise Makes Two C-Suite Appointments
David Killengray Named Chief Commercial Officer and Rebecca Rose Elevated to Chief Operations Officer
Strasbourg, FR - (1 May, 2024) - Medevise Consulting SAS, a strategic consultancy that partners with ophthalmic companies to bring innovative products to market, announced today that it has added two executives to its C-suite. David Killengray has been appointed Chief Commercial Officer, and Rebecca Rose has been elevated to the role of Chief Operations Officer.
“I have known David for more than 25 years when we were part of the newly formed Bausch+Lomb surgical business, going on to work together on various projects over the years” said Kristine Morrill, Founder and President. “Rebecca has been a key member of the Medevise management team for more than two years and has been critical to the company’s growth.”
In his new role, David will be responsible for overseeing and managing all commercial aspects of the company’s operations, with a primary focus on driving revenue generation, business growth, and profitability. In her new role, Rebecca will focus on the company’s daily business operations and administration, as well as overseeing Medevise’s services delivery to ensure a high degree of client satisfaction.
David Killengray has 35 years of experience leading commercial operations for ophthalmic businesses. As a medical device and capital equipment business professional, David possesses highly developed sales, marketing, and business development skills. His unique expertise lies in distributor selection and management, plus new product development and launch from roles at large strategic organizations including Bausch+Lomb. He has held senior leadership roles at major healthcare and distributor organizations across Europe and has impacted every aspect of the sales and marketing for ophthalmic devices.
“Medevise has quickly become one of the largest providers of ophthalmic clinical study services in Europe and is expanding its footprint in commercialization services,” said David. “I am pleased to join at such an exciting time of growth for this company and look forward to contributing to its future success.”
Rebecca Rose previously served as Director of Consulting Services. A veteran leader with deep expertise in operational management and client service, Rebecca brings more than 25 years of experience growing businesses across a variety of industries with clients such as Microsoft, Marriott, Jaguar, Land Rover, Proctor & Gamble, and more.
“The Medevise team is a unique group of scientific and strategic thinkers and leaders,” said Rebecca. “Leading the operational success of this business is an exciting and fulfilling endeavor, and I look forward to continuing to support our clients in bringing innovative technologies to market.”
David will be located in Medevise’s UK office, while Rebecca will work from the Strasbourg headquarters. Both report directly to Medevise’s president and founder Kristine Morrill.
About Medevise Consulting
Medevise is a strategic consultancy that supports ophthalmic companies in bringing innovative technologies to market. With a senior-level, global team, Medevise provides regulatory, clinical, market access, and marketing communication services all in one place with unparalleled insight, resources and a network built up over decades of experience. Medevise is driven to ensure the best innovation from medical device companies gets into the hands of ophthalmologists to improve patient experience and outcomes. Learn more at www.medevise-consulting.com.
About Medevise Launchpad
Medevise Launchpad is a commercialization solution for medical companies seeking to launch in Europe. This incubator model streamlines the go-to-market process, immediately placing experienced leadership along with expert resources to quickly and efficiently develop a commercialization roadmap, assess market opportunities, connect with a targeted KOL network, drive the CE mark process, develop a go-to-market strategy, and tackle reimbursement across multiple markets. Launchpad enables companies to hit the ground running, significantly shortening their go-to-market timeline and pinpointing the optimal strategies for success with expert guidance and support.